Related Experiment Videos
Narcotic abstinence in dependent rats: EEG and behavioral correlates
Pharmacology, Biochemistry, and Behavior
|July 1, 1980
Summary
Opioid abstinence severity varied among rats. Long-acting beta-agonists (LAAM) showed the mildest withdrawal symptoms compared to morphine, methadone, and other tested narcotics.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Opioid dependence and withdrawal present significant challenges in addiction research.
- Understanding the differential effects of various opioids is crucial for developing effective treatments.
- Rat models are commonly used to study the neurobiological and behavioral aspects of drug dependence and withdrawal.
Purpose of the Study:
- To compare the electroencephalogram (EEG) and behavioral indicators of withdrawal from five different narcotic agonists in dependent rats.
- To assess the varying severity of abstinence syndromes induced by morphine, methadone, long-acting beta-agonists (LAAM), NLAAM, and DNLAAM.
Main Methods:
- Rats were trained to self-administer opioids via lever pressing on a fixed-ratio 20 schedule.
- Following established dependence, saline was substituted for each opioid agonist.
- EEG and behavioral responses, including lever pressing and head-shakes, were monitored during abstinence.
Main Results:
- REM sleep suppression was observed during abstinence from morphine, methadone, and NLAAM, but not LAAM or DNLAAM.
- Increased lever pressing for saline and head-shake behaviors were prominent during withdrawal from morphine, methadone, NLAAM, and DNLAAM.
- Abstinence from LAAM and DNLAAM was associated with delayed onset of increased lever pressing compared to other opioids.
Conclusions:
- Significant pharmacodynamic differences exist among the studied narcotic agonists.
- Abstinence from LAAM in dependent rats resulted in the least severe withdrawal syndrome compared to morphine, methadone, NLAAM, and DNLAAM.
- These findings highlight LAAM as a potentially less severe option in opioid substitution therapy, warranting further investigation.